Please enable JavaScript to continue using this application.

Compare $CGON vs $ORKA | Chartloom

Compare

$CGON vs $ORKA

CG Oncology Inc · Oruka Therapeutics Inc

CGON

CG Oncology Inc

ORKA

Oruka Therapeutics Inc

Compare $CGON vs $ORKA

Comparing CG Oncology Inc and Oruka Therapeutics Inc

CGONCG Oncology Inc

ORKAOruka Therapeutics Inc

CGONCG Oncology Inc

Market cap

$5.63B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

135.78x

Rev growth (TTM)

1030.3%

YTD performance

52.7%

52W performance

56.8%

FCF yield

-3.2%

ORKAOruka Therapeutics Inc

Market cap

$4.95B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

190.4%

52W performance

263.0%

FCF yield

-2.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CGON

ORKA

Detailed metrics comparison

CGON

CG Oncology Inc

ORKA

Oruka Therapeutics Inc

Market Cap

CGON$5.63B

ORKA$4.95B

Enterprise Value

CGON$5.61B

ORKA$4.68B

Price

CGON$63.82

ORKA$82.11

P/E Ratio

CGONN/A

ORKAN/A

P/S Ratio

CGON903.81x

ORKA119.42x

EV/Sales

CGON901.14x

ORKA113.69x

EV/EBITDA

CGON0.00x

ORKA0.00x

P/B Ratio

CGON5.80x

ORKA5.02x

P/FCF Ratio

CGONN/A

ORKAN/A

EV/FCF

CGON-31.29x

ORKA-46.30x

PEG Ratio

CGONN/A

ORKAN/A

Forward P/E (NTM)

CGONN/A

ORKAN/A

Forward P/S (NTM)

CGON135.78x

ORKAN/A

Revenue (TTM)

CGON$6M

ORKA$0

Revenue Growth (YoY)

CGON1030.3%

ORKAN/A

Forward Rev Growth

CGON1916.0%

ORKA679.2%

Gross Margin (TTM)

CGON-85.2%

ORKA0.0%

Operating Margin (TTM)

CGON0.0%

ORKA0.0%

EBITDA Margin (TTM)

CGON-4008.7%

ORKA0.0%

Net Margin (TTM)

CGON-3602.7%

ORKA0.0%

FCF Margin (TTM)

CGON-2879.6%

ORKAN/A

Net Income (TTM)

CGON$-224M

ORKA$-133M

FCF (TTM)

CGON$-179M

ORKA$-101M

EPS (TTM)

CGON-$2.54

ORKA-$2.11

ROE (TTM)

CGON-2520.0%

ORKA-2076.0%

ROA (TTM)

CGON-2398.0%

ORKA-2012.0%

ROIC (TTM)

CGON-2512.0%

ORKA-2076.0%

Cash

CGON$20M

ORKA$268M

Debt

CGON$3M

ORKA$0

Net Cash/Debt

CGON$17M

ORKA$268M

Current Ratio (TTM)

CGON22.22x

ORKA38.51x

Quick Ratio (TTM)

CGON21.78x

ORKA38.03x

Debt/Equity (TTM)

CGON0.00x

ORKA0.00x

Debt/Assets (TTM)

CGON0.0%

ORKA0.0%

Interest Coverage (TTM)

CGONN/A

ORKAN/A

Net Debt/EBITDA (TTM)

CGON0.00x

ORKA0.00x

Beta

CGON0.25

ORKA-0.40

52W Performance

CGON56.8%

ORKA263.0%

YTD Performance

CGON52.7%

ORKA190.4%

% from 52W High

CGON-21.2%

ORKA-28.9%

% from 52W Low

CGON78.3%

ORKA279.1%

Asset Turnover (TTM)

CGON0.01x

ORKA0.33x

FCF Yield (TTM)

CGON-3.2%

ORKA-2.0%

Earnings Yield (TTM)

CGON-4.0%

ORKA-2.7%

Dividend Yield (TTM)

CGONN/A

ORKAN/A

Rule of 40

CGON-1,849.3

ORKA0.0

EV/GP/RG

CGONN/A

ORKAN/A

Ticker research

View CGON research View ORKA research

Metric	CGON CG Oncology Inc	ORKA Oruka Therapeutics Inc
Market & Valuation
Market Cap	$5.63B	$4.95B
Enterprise Value	$5.61B	$4.68B
Price	$63.82	$82.11
P/E Ratio	N/A	N/A
P/S Ratio	903.81x	119.42x
EV/Sales	901.14x	113.69x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.80x	5.02x
P/FCF Ratio	N/A	N/A
EV/FCF	-31.29x	-46.30x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	135.78x	N/A
Revenue & Growth
Revenue (TTM)	$6M	$0
Revenue Growth (YoY)	1030.3%	N/A
Forward Rev Growth	1916.0%	679.2%
Profitability
Gross Margin (TTM)	-85.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-4008.7%	0.0%
Net Margin (TTM)	-3602.7%	0.0%
FCF Margin (TTM)	-2879.6%	N/A
Net Income (TTM)	$-224M	$-133M
FCF (TTM)	$-179M	$-101M
EPS (TTM)	-$2.54	-$2.11
ROE (TTM)	-2520.0%	-2076.0%
ROA (TTM)	-2398.0%	-2012.0%
ROIC (TTM)	-2512.0%	-2076.0%
Financial Health
Cash	$20M	$268M
Debt	$3M	$0
Net Cash/Debt	$17M	$268M
Current Ratio (TTM)	22.22x	38.51x
Quick Ratio (TTM)	21.78x	38.03x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.25	-0.40
52W Performance	56.8%	263.0%
YTD Performance	52.7%	190.4%
% from 52W High	-21.2%	-28.9%
% from 52W Low	78.3%	279.1%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.33x
FCF Yield (TTM)	-3.2%	-2.0%
Earnings Yield (TTM)	-4.0%	-2.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,849.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CGON research	View ORKA research

Valuation

P/S Ratio

ORKA

119.42x

CGON

903.81x

EV/FCF

ORKA

-46.30x

CGON

-31.29x

Growth & revenue

Revenue Growth TTM

CGON

1030.3%

Forward Revenue Growth

CGON

1916.0%

ORKA

679.2%

Profitability & performance

Gross Margin

ORKA

0.0%

CGON

-85.2%

ROE

ORKA

-2076.0%

CGON

-2520.0%

FCF Yield %

ORKA

-2.0%

CGON

-3.2%

52-Week Performance

ORKA

263.0%

CGON

56.8%

Detailed metrics comparison

CGON

CG Oncology Inc

ORKA

Oruka Therapeutics Inc

Market Cap

CGON$5.63B

ORKA$4.95B

Enterprise Value

CGON$5.61B

ORKA$4.68B

Price

CGON$63.82

ORKA$82.11

P/E Ratio

CGONN/A

ORKAN/A

P/S Ratio

CGON903.81x

ORKA119.42x

EV/Sales

CGON901.14x

ORKA113.69x

EV/EBITDA

CGON0.00x

ORKA0.00x

P/B Ratio

CGON5.80x

ORKA5.02x

P/FCF Ratio

CGONN/A

ORKAN/A

EV/FCF

CGON-31.29x

ORKA-46.30x

PEG Ratio

CGONN/A

ORKAN/A

Forward P/E (NTM)

CGONN/A

ORKAN/A

Forward P/S (NTM)

CGON135.78x

ORKAN/A

Revenue (TTM)

CGON$6M

ORKA$0

Revenue Growth (YoY)

CGON1030.3%

ORKAN/A

Forward Rev Growth

CGON1916.0%

ORKA679.2%

Gross Margin (TTM)

CGON-85.2%

ORKA0.0%

Operating Margin (TTM)

CGON0.0%

ORKA0.0%

EBITDA Margin (TTM)

CGON-4008.7%

ORKA0.0%

Net Margin (TTM)

CGON-3602.7%

ORKA0.0%

FCF Margin (TTM)

CGON-2879.6%

ORKAN/A

Net Income (TTM)

CGON$-224M

ORKA$-133M

FCF (TTM)

CGON$-179M

ORKA$-101M

EPS (TTM)

CGON-$2.54

ORKA-$2.11

ROE (TTM)

CGON-2520.0%

ORKA-2076.0%

ROA (TTM)

CGON-2398.0%

ORKA-2012.0%

ROIC (TTM)

CGON-2512.0%

ORKA-2076.0%

Cash

CGON$20M

ORKA$268M

Debt

CGON$3M

ORKA$0

Net Cash/Debt

CGON$17M

ORKA$268M

Current Ratio (TTM)

CGON22.22x

ORKA38.51x

Quick Ratio (TTM)

CGON21.78x

ORKA38.03x

Debt/Equity (TTM)

CGON0.00x

ORKA0.00x

Debt/Assets (TTM)

CGON0.0%

ORKA0.0%

Interest Coverage (TTM)

CGONN/A

ORKAN/A

Net Debt/EBITDA (TTM)

CGON0.00x

ORKA0.00x

Beta

CGON0.25

ORKA-0.40

52W Performance

CGON56.8%

ORKA263.0%

YTD Performance

CGON52.7%

ORKA190.4%

% from 52W High

CGON-21.2%

ORKA-28.9%

% from 52W Low

CGON78.3%

ORKA279.1%

Asset Turnover (TTM)

CGON0.01x

ORKA0.33x

FCF Yield (TTM)

CGON-3.2%

ORKA-2.0%

Earnings Yield (TTM)

CGON-4.0%

ORKA-2.7%

Dividend Yield (TTM)

CGONN/A

ORKAN/A

Rule of 40

CGON-1,849.3

ORKA0.0

EV/GP/RG

CGONN/A

ORKAN/A

Ticker research

View CGON research View ORKA research

Metric	CGON CG Oncology Inc	ORKA Oruka Therapeutics Inc
Market & Valuation
Market Cap	$5.63B	$4.95B
Enterprise Value	$5.61B	$4.68B
Price	$63.82	$82.11
P/E Ratio	N/A	N/A
P/S Ratio	903.81x	119.42x
EV/Sales	901.14x	113.69x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.80x	5.02x
P/FCF Ratio	N/A	N/A
EV/FCF	-31.29x	-46.30x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	135.78x	N/A
Revenue & Growth
Revenue (TTM)	$6M	$0
Revenue Growth (YoY)	1030.3%	N/A
Forward Rev Growth	1916.0%	679.2%
Profitability
Gross Margin (TTM)	-85.2%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-4008.7%	0.0%
Net Margin (TTM)	-3602.7%	0.0%
FCF Margin (TTM)	-2879.6%	N/A
Net Income (TTM)	$-224M	$-133M
FCF (TTM)	$-179M	$-101M
EPS (TTM)	-$2.54	-$2.11
ROE (TTM)	-2520.0%	-2076.0%
ROA (TTM)	-2398.0%	-2012.0%
ROIC (TTM)	-2512.0%	-2076.0%
Financial Health
Cash	$20M	$268M
Debt	$3M	$0
Net Cash/Debt	$17M	$268M
Current Ratio (TTM)	22.22x	38.51x
Quick Ratio (TTM)	21.78x	38.03x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.25	-0.40
52W Performance	56.8%	263.0%
YTD Performance	52.7%	190.4%
% from 52W High	-21.2%	-28.9%
% from 52W Low	78.3%	279.1%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.33x
FCF Yield (TTM)	-3.2%	-2.0%
Earnings Yield (TTM)	-4.0%	-2.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,849.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CGON research	View ORKA research